ロード中...
Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
Immunogenicity and safety of a recombinant, live-attenuated, tetravalent dengue disease vaccine (CYD-TDV) was evaluated in children/adolescents in Brazil. In this observer-blind, placebo-controlled, phase II single-center study, children/adolescents (ages 9–16 years) were randomized to receive CYD-T...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society of Tropical Medicine and Hygiene
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854882/ https://ncbi.nlm.nih.gov/pubmed/24189367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.13-0304 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|